Effectiveness willow bark

Willow bark works about as well as ibuprofen for osteoarthritis pain, with fewer stomach side effects. That is a real finding from a 2025 head-to-head trial.

The 2025 study compared 240 mg of salicin (the active compound in willow bark) against 1200 mg of ibuprofen daily for 12 weeks in 120 people with knee osteoarthritis [2]. Pain dropped by about the same amount in both groups: VAS scores fell from 7.4 to 3.1 with willow bark and from 7.6 to 3.0 with ibuprofen. The difference between the two was not statistically significant (p = 0.12) [2]. Inflammatory markers like CRP and IL-6 also fell similarly [2]. The willow bark group had a notably lower rate of adverse events: 10% reported nausea or diarrhea, compared to 25% in the ibuprofen group who had stomach discomfort, headache, or elevated liver enzymes [2]. One interesting difference: willow bark reduced MMP-3 by 30% while ibuprofen had no effect (p < 0.01), which suggests an additional mechanism beyond COX inhibition [2].

Older studies support the same direction. A 2000 trial of 210 people with chronic low back pain found that 39% of those on 240 mg salicin were pain-free after 4 weeks, compared to 6% on placebo [1]. A 2013 review confirmed analgesic and anti-inflammatory effects with generally mild safety concerns [1]. The main downside is slower onset: willow bark took about 14 days to reach full effect, versus 7 days for ibuprofen [2].

The evidence here is from independent clinical trials, not manufacturer-funded studies. The 2025 trial appears to be academic research [2]. The older studies were also investigator-initiated [1]. That matters: this is not industry marketing dressed up as science.

My call: willow bark extract at 240 mg salicin daily is a genuinely effective pain reliever for osteoarthritis and low back pain, comparable to standard doses of ibuprofen but with fewer gastrointestinal side effects. The main trade-off is slower onset. Confidence: moderate.